SITE MAP

patient

  • 01

    About the test

    what is NICE® prenatal test?

    NICE® is a non-invasive prenatal test (NIPT) that detects fetal DNA in maternal plasma during pregnancy through Next Generation Sequencing (NGS). It can be tested from the 10th week of pregnancy and evaluates fetal chromosomal abnormalities. NICE® screens for common trisomy (such as 21, 18, 13), sex chromosome aneuploidies and analyzes eight clinically important microdeletion regions.

NICE® vs traditional prenatal screening

NICE® is a non-invasive prenatal test (NIPT) that detects fetal DNA in maternal plasma during pregnancy through Next Generation Sequencing (NGS). It can be tested from the 10th week of pregnancy and evaluates fetal chromosomal abnormalities. NICE® screens for common trisomy (such as 21, 18, 13) , sex chromosome aneuploidies and analyzes eight clinically important microdeletion regions.

  • Screening
  • How to
  • Since when
  • How long
  • Detection rate%
  • NIPT
  • NICE
  • Non-invasive
  • From 10 weeks
  • 7~10 days
  • >99%
  • Conventional
    Blood Test

  • Triple Screen

    Quadruple Screen

  • Non-invasive
  • From 11-13 weeks
  • 2 days

  • 67~71%

    79~81%

  • Integrated
    Screening Test
  • Integrated Screen
  • Non-invasive
  • From 11-13 weeks
  • 4~5 weeks
  • 94~96%
  • Cell Culture
    Test

  • Chorionic Screen

    Amniocentesis

  • invasive
  • From 11-13 weeks
  • 1~2 weeks
  • >99%

  • 02

    How it works

    how is the NICE® performed

    NICE® looks at isolated fetal cfDNA present in maternal blood, collected after 10 weeks of pregnancy from massively parallel WGS. Sequencing data is analyzed by applying the bioinformatics pipeline.

  • ⓒ[2022]. Eone Diagnomics Genome Center Co., Ltd. All Rights Reserved.
  • Internal Information Management Regulation | Privacy Policy